Related Experiment Video

Updated: May 26, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon

Xinxin Song1, Han-Cheon Kim, Seog-Young Kim

  • 1Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.

Journal of Cellular Biochemistry
|December 17, 2011
PubMed

Insights

This study compared mapatumumab (Mapa) and TRAIL with hyperthermia for treating colorectal cancer liver metastases. Mapa combined with hyperthermia shows promise for treating these metastases.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunotherapy

Background:

  • Colorectal cancer is a leading cause of cancer mortality, often due to metastasis.
  • Hyperthermia combined with TNF-related apoptosis-inducing ligand (TRAIL) is a potential treatment for liver metastases.
  • TRAIL can cause hepatocyte toxicity, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To evaluate the anti-tumor efficacy of mapatumumab (Mapa), an anti-death receptor 4 (DR4) antibody, in combination with hyperthermia.
  • To compare the efficacy of Mapa plus hyperthermia with TRAIL plus hyperthermia for treating hepatic colorectal metastases.

Main Methods:

  • Comparison of apoptosis induction by TRAIL and Mapa.
  • Assessment of hyperthermia's effect on apoptosis induced by TRAIL and Mapa.
  • Investigation of the molecular mechanisms underlying the synergistic effects.

Main Results:

  • Hyperthermia significantly enhances apoptosis induced by both TRAIL and Mapa.
  • TRAIL was more potent than Mapa in inducing apoptosis alone.
  • The synergistic effects involve reactive oxygen species, JNK activation, mitochondrial pathways, and caspase activation.

Conclusions:

  • Mapa in combination with hyperthermia demonstrates anti-tumor efficacy against colorectal liver metastases.
  • This combination therapy offers a potential alternative to TRAIL, mitigating hepatocyte toxicity.
  • Further studies are warranted to support the clinical application of Mapa and hyperthermia for metastatic colorectal cancer.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.